Review
Accepted on 07 May 2024
Extracellular vescicles in psoriasis: from pathogenesis to possible roles in therapy
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1360618
Type at least 3 characters
1,053 articles
Articles
Original Research
Accepted on 07 May 2024
Whole blood culture-derived cytokine combinations for the diagnosis of tuberculosis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1397941
Original Research
Accepted on 06 May 2024
The predictive value of TNF family for pulmonary tuberculosis: A pooled causal effect analysis of multiple datasets
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1398403
Original Research
Accepted on 01 May 2024
LTβR-RelB signaling in intestinal epithelial cells protects from chemotherapy-induced mucosal damage
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1388496
Original Research
Accepted on 29 Apr 2024
IFNγ at the early stage induced after cryo-thermal therapy maintains CD4 + Th1-prone differentiation, leading to long-term antitumor immunity
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1345046
Original Research
Accepted on 29 Apr 2024
Distinct TB-Antigen Stimulated Cytokine Profiles as Predictive Biomarkers for Unfavorable Treatment Outcomes in Pulmonary Tuberculosis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1392256
Review
Accepted on 29 Apr 2024
Regulation of Treg Cells by Cytokine Signaling and Co-Stimulatory Molecules
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1387975
Original Research
Published on 29 Apr 2024
Exploring causal correlations between inflammatory cytokines and Ménière’s disease: a Mendelian randomization
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1373723
- 329 views
Review
Published on 26 Apr 2024
Chemokines and lymphocyte homing in Sjögren’s syndrome
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1345381
- 239 views
Original Research
Published on 26 Apr 2024
Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1382931
- 323 views
Original Research
Accepted on 25 Apr 2024
The Atypical Chemokine Receptor 2 Reduces T Cell Expansion and Tertiary Lymphoid Tissue But Does Not Limit Autoimmune Organ Injury In Lupus-Prone B6lpr Mice
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1377913
Review
Published on 24 Apr 2024
The Immunomodulatory effect of exosomes in diabetes: a novel and attractive therapeutic tool in diabetes therapy
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1357378
- 312 views
Original Research
Accepted on 22 Apr 2024
The Disruptive Effects of COPD Exacerbation-Associated Factors on Epithelial Repair Responses
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1346491
Original Research
Accepted on 22 Apr 2024
MCP-3 as a Prognostic Biomarker for Severe Fever with Thrombocytopenia Syndrome: A Longitudinal Cytokine Profile Study Authors：
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1379114
Original Research
Accepted on 22 Apr 2024
Inflammatory and Endothelial Host Responses in Community-Acquired Pneumonia: Exploring the Relationships with HbA1c, Admission Plasma Glucose, and Glycaemic Gap -A Cross-Sectional Study
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1372300
Original Research
Published on 22 Apr 2024
The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1360140
- 515 views